These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21575751)

  • 1. The editor's roundtable: anemia and cardiovascular disease.
    Friedewald VE; Emmett M; McCullough P; Yancy CW; Roberts WC
    Am J Cardiol; 2011 Jun; 107(11):1630-5. PubMed ID: 21575751
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of anemia in chronically dialyzed patients].
    Moynot A
    Nephrologie; 1998; 19(3):125-7. PubMed ID: 9633055
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular effects of erythropoietin: anemia and beyond.
    Guglin ME; Koul D
    Cardiol Rev; 2006; 14(4):200-4. PubMed ID: 16788333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The deadly triangle of anemia, renal insufficiency, and cardiovascular disease: implications for prognosis and treatment.
    McCullough PA; Lepor NE
    Rev Cardiovasc Med; 2005; 6(1):1-10. PubMed ID: 15741920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anemia and quality of life in cancer patients: impact of transfusion and erythropoietin.
    Thomas ML
    Med Oncol; 1998 Aug; 15 Suppl 1():S13-8. PubMed ID: 9785332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin is equally effective as fresh-blood transfusion at reducing infarct size in anemic rats.
    Xenocostas A; Hu H; Chin-Yee N; Lu X; Chin-Yee I; Feng Q
    Crit Care Med; 2010 Nov; 38(11):2215-21. PubMed ID: 20693887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of anemia in renal failure].
    Siciński A
    Pol Tyg Lek; 1974 Nov; 29(44):1895-8. PubMed ID: 4610533
    [No Abstract]   [Full Text] [Related]  

  • 8. Erythropoietin for anemia of cancer: higher hematocrits, fewer transfusions.
    Oncology (Williston Park); 1992 Sep; 6(9):19. PubMed ID: 1449973
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential mechanisms of adverse outcomes in trials of anemia correction with erythropoietin in chronic kidney disease.
    Vaziri ND; Zhou XJ
    Nephrol Dial Transplant; 2009 Apr; 24(4):1082-8. PubMed ID: 18987263
    [No Abstract]   [Full Text] [Related]  

  • 10. [General principles of treatment of anemia in cancer patients].
    Spaeth D
    Bull Cancer; 2002 Nov; 89(11):935-47. PubMed ID: 12495881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HuEPO treatment of anemia in preterm infants].
    Galligani L; Perona A
    Minerva Pediatr; 1994 Nov; 46(11):521-6. PubMed ID: 7870011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.
    van Kaam AH; Egeler RM
    Cancer; 1996 Sep; 78(5):1144-5. PubMed ID: 8780558
    [No Abstract]   [Full Text] [Related]  

  • 13. [Erythropoietin in hematology and oncology. I. Chronic anemia in malignant disease and the pharmacology of erythropoietin].
    Adam Z; Krejcí M; Vorlícek J
    Vnitr Lek; 1996 Apr; 42(4):285-9. PubMed ID: 8693717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical spectrum of iron overload, novel uses of iron chelators, and potential treatment of pediatric anemias with erythropoietin. Introduction.
    Cairo MS
    Am J Pediatr Hematol Oncol; 1990; 12(1):1-3. PubMed ID: 2178456
    [No Abstract]   [Full Text] [Related]  

  • 15. [Conservative treatment of infection and tumor anemia].
    Kubanek B
    Dtsch Med Wochenschr; 1979 Feb; 104(7):238-40. PubMed ID: 761512
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anemia impact on treatments of cervical carcinomas].
    Marchal C; Rangeard L; Brunaud C
    Cancer Radiother; 2005 Mar; 9(2):87-95. PubMed ID: 15820436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autologous blood transfusion with erythropoietin in heart surgery in an anemic patient].
    Watanabe Y; Fuse K; Naruse Y; Kobayashi T; Konishi H; Shibata Y
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Feb; 40(2):282-5. PubMed ID: 1593170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anemia in the critically ill.
    Shander A
    Crit Care Clin; 2004 Apr; 20(2):159-78. PubMed ID: 15135458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New applications of erythropoietin in cardiovascular disease: from haematopoiesis to cardiac protection].
    van der Meer P; van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 2008 Apr; 152(16):923-7. PubMed ID: 18561787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin versus iron chelators in anaemia and iron overload.
    Vreugdenhil G; van Herpen C; Koene RA
    Neth J Med; 1993 Feb; 42(1-2):45-7. PubMed ID: 8446223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.